Org-13011 fumarate

CAS No. 142494-13-1

Org-13011 fumarate( —— )

Catalog No. M34363 CAS No. 142494-13-1

Org-13011 fumarate1 is an agonist of the 5-HT1A receptor and can be used to study neurological disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 411 In Stock
10MG 562 In Stock
25MG 866 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Org-13011 fumarate
  • Note
    Research use only, not for human use.
  • Brief Description
    Org-13011 fumarate1 is an agonist of the 5-HT1A receptor and can be used to study neurological disorders.
  • Description
    Org-13011 fumarate1 is an agonist of the 5-HT1A receptor and can be used to study neurological disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    142494-13-1
  • Formula Weight
    486.48
  • Molecular Formula
    C22H29F3N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C/C(O)=O)\C(O)=O.C(F)(F)(F)C=1C=C(N=CC1)N2CCN(CCCCN3C(=O)CCC3)CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SB 216641 hydrochlor...

    SB 216641 hydrochloride (SB-216641A) is a selective 5-HT1B/D receptor antagonist with anxiolytic properties that antagonizes the vasoconstrictor response mediated by sumatriptan.

  • Lumateperone

    Lumateperone (ITI-007) is a potent 5-HT2A antagonist (Ki=0.54 nM), postsynaptic D2 antagonist(Ki=32 nM), and SERT blocker (Ki= 61 nM).

  • (Rac)-Norcisapride

    Norcisapride is a 5-hydroxytryptamine receptor 3 (5-HT3) and (5-hydroxytryptamine receptor 4 (5-HT4) dual agonist used for the treatment of gastrointestinal disorders, orofacial disorders, and otorhinolaryngologic disorders.